Results 121 to 130 of about 600 (148)
Some of the next articles are maybe not open access.
ANZ Journal of Surgery, 1998
Background:Patients referred to general surgeons for the treatment of gall‐bladder stones were studied to evaluate the role of sincalide cholescintigraphy as a gall‐bladder stress test in an effort to identify a group of patients whose pain was non‐biliary in origin and who would not be improved by cholecystectomy.Methods:Ten asymptomatic controls and ...
Jon Gani
exaly +3 more sources
Background:Patients referred to general surgeons for the treatment of gall‐bladder stones were studied to evaluate the role of sincalide cholescintigraphy as a gall‐bladder stress test in an effort to identify a group of patients whose pain was non‐biliary in origin and who would not be improved by cholecystectomy.Methods:Ten asymptomatic controls and ...
Jon Gani
exaly +3 more sources
Digestive Diseases and Sciences, 1981
The effects of intramuscular and intravenous sincalide on gallbladder contraction and visualization of the bile ducts were compared in a group of 37 subjects referred for oral cholecystography. The maximum reduction in gallbladder size observed after sincalide 400 ng/kg intramuscular, 54.7 +/- 7.2% (mean +/- SEM), occurred 25 min after injection and ...
Donald E Wilson
exaly +3 more sources
The effects of intramuscular and intravenous sincalide on gallbladder contraction and visualization of the bile ducts were compared in a group of 37 subjects referred for oral cholecystography. The maximum reduction in gallbladder size observed after sincalide 400 ng/kg intramuscular, 54.7 +/- 7.2% (mean +/- SEM), occurred 25 min after injection and ...
Donald E Wilson
exaly +3 more sources
Use of CCK agonist sincalide for diagnostic and therapeutic ERCP
Gastrointestinal Endoscopy, 1996Allan P Weston
exaly +2 more sources
Chemical Stability of Reconstituted Sincalide in Sterile Water Under 2 Different Storage Conditions [PDF]
This study aimed to evaluate the chemical stability of sincalide at 2 common storage conditions-room temperature and refrigeration-in an attempt to simulate the conditions faced during centralized reconstitution and subsequent distribution to regional clinical facilities.
Eric, Belanger +4 more
exaly +3 more sources
Kinevac (Sincalide for Injection)/Squibb Diagnostics
Gastroenterology Nursing, 1991Sincalide is a rapid-acting, synthetic analog of cholecystokinin for intravenous use in postevacuation cholecystography. Serious reactions to sincalide have not been reported. The intravenous administration of sincalide causes a prompt contraction of the gallbladder as compared to the stimulus of a fatty meal which causes progressive contraction that ...
openaire +2 more sources
Seminars in Nuclear Medicine, 2012
Sincalide cholescintigraphy was first reported to have clinical utility in 1980. Since then, many publications have found that a reduced gallbladder ejection fraction (GBEF) can confirm the clinical diagnosis of acalculous chronic gallbladder disease and predict symptomatic relief with cholecystectomy.
Harvey A Ziessman
exaly +3 more sources
Sincalide cholescintigraphy was first reported to have clinical utility in 1980. Since then, many publications have found that a reduced gallbladder ejection fraction (GBEF) can confirm the clinical diagnosis of acalculous chronic gallbladder disease and predict symptomatic relief with cholecystectomy.
Harvey A Ziessman
exaly +3 more sources
Clinical Nuclear Medicine, 2020
Objective To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the ...
Justin G Peacock, Kevin P Banks
exaly +3 more sources
Objective To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the ...
Justin G Peacock, Kevin P Banks
exaly +3 more sources
Practical Hepatobiliary Imaging Using Pretreatment with Sincalide in 139 Hepatobiliary Studies
Clinical Nuclear Medicine, 1985Hepatobiliary studies were performed over a three-year period on 139 patients suspected of having cystic duct obstruction. Each patient was infused intravenously with sincalide, a C-terminal octapeptide of CCK, 15 minutes prior to the administration of the hepatobiliary imaging agent Tc-99m paraisopropyl iminodiacetic acid (PIPIDA).
F K, Patterson, J W, Kam
openaire +2 more sources
Clinical Nuclear Medicine, 1995
An 82-year-old man had his third episode of melanotic stool. Two previous workups had failed to localize the source of bleeding. A Tc-99m labeled RBC scan visualized the gallbladder early in the study. Administration of sincalide visually decreased the activity, confirming gallbladder activity.
M E, Spieth +5 more
openaire +2 more sources
An 82-year-old man had his third episode of melanotic stool. Two previous workups had failed to localize the source of bleeding. A Tc-99m labeled RBC scan visualized the gallbladder early in the study. Administration of sincalide visually decreased the activity, confirming gallbladder activity.
M E, Spieth +5 more
openaire +2 more sources
Artificial Intelligence in Sincalide-Stimulated Cholescintigraphy: A Pilot Study
Clinical Nuclear MedicinePurpose: Sincalide-stimulated cholescintigraphy (SSC) calculates the gallbladder ejection fraction (GBEF) to diagnose functional gallbladder disorder. Currently, artificial intelligence (AI)-driven workflows that integrate real-time image processing and organ function calculation remain unexplored in nuclear medicine practice ...
Nghi C. Nguyen +4 more
openaire +2 more sources

